12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

BioAlliance, Par Pharmaceutical sales and marketing update

Par's Strativa Pharmaceuticals unit launched Oravig miconazole in the U.S. to treat oropharyngeal candidiasis....

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >